Leukopenia and Hepatotoxicity

Abstract

A case report of a 72-year-old white female who was treated with a total of 260 mg chlorpromazine and who rapidly developed elevated serum glutamic oxalacetic transaminase, direct and total bilirubin, alkaline phosphatase, and lactic dehydrogenase and whose peripheral white blood cell count dropped to 2,500/mm³' is presented. The bone marrow was found to be hypocellular. Approximately 15 days following discontinuance of the drug, the laboratory values returned toward normal with marked clinical improvement in the patient.

The possibility of other drugs causing similar changes in this patient is discussed as are the adverse effects of phenothiazines and methods of monitoring the patient who is receiving phenothiazine therapy.

Get full access to this article

View all access options for this article.

References

Meyler

Herxheimer

: Side Effects of Drugs, Vol. 7, Excerpta Medica, Amsterdam, 1972, p. 76–79.

Byck

: Drugs and the Treatment of Psychiatric Disorders, Chapter 12, The Pharmacological Basis of Therapeutics, 5th ed., The Macmillan Co., New York, N.Y., 1975, p. 164.

Fenster

L. F.

: Hepatic and Gastrointestinal Disorders, Chapter 4, Clinical Pharmacology—Basic Principles in Therapeutics, The Macmillan Co., New York, N.Y., 1972, p. 107.

Dujovne

C. A.

Zimmerman

H. J.

: Cytotoxicity of Phenothiazines on Chang Liver Cells as Measured by Enzyme Leakage, Proc. Soc. Exp. Biol. Med. (N.Y.) 131: 583, 1969.

Hollister

L. E.

: Psychiatric and Neurologic Disorders, Clinical Pharmacology—Basic Principles in Therapeutics, The Macmillan Co., New York, N.Y., 1972.

Mandel

Gross

: Agranulocytosis and Phenothiazines, Dis. Nerv. Syst. 29: 32, 1968.

Pisciotta

A. Y.

: Agranulocytosis Induced by Certain Phenothiazine Derivatives, J. Am. Med. Assoc. 208: 1862, 1969.

Hollister

L. E.

Caffey

E. M.

Jr. Klett

C. J.

: Abnormal Symptoms, Signs and Laboratory Tests during Treatment with Phenothiazine Derivatives, Clin. Pharmacol. Ther. 1: 284–293, 1969.

Erslev

A. J.

Wintrobe

M. M.

: Detection and Prevention of Drug-Induced Blood Dyscrasias, J. Am. Med. Assoc. 181: 114–119, 1962.

10.

Ayd

F. J.

Jr. : Chlorpromazine: Ten Year's Experience. J. Am. Med. Assoc. 184: 173–176, 1963.

11.

Pisciotta

A. V.

Ebbe

Lennon

E. J.

Metzger

G. O.

Madison

F. W.

: Agranulocytosis Following Administration of Phenothiazine Derivatives, Am. J. Med. 25: 210–223, 1958.

12.

Mandel

Gross

: Agranulocytosis and Phenothiazines, Dis. Nerv. Syst. 29: 32, 1968.

13.

Ayd

F. J.

Jr. : Phenothiazine-Induced Agranulocytosis: The “At-Risk” Patient. Int. Drug Ther. Newslet. 4: 13–20, 1969.

14.

Pisciotta

A. V.

: Mechanisms of Phenothiazine-Induced Agranulocytosis. In Psycho pharmacology, A Review of Progress 1957–1967, edited by Efron

D. H.

, Washington, D.C.: US Government Printing Office, 1968, pp. 597–605.

15.

Huguley

C. M.

Jr. : Drug-Induced Blood Dyscrasias, Dis. Mon.: October, 1963.